申请人:Eggenweiler Hans-Michael
公开号:US20050059686A1
公开(公告)日:2005-03-17
Pyrrolopyrimidine derivatives of the formula I
in which R
3
, R
4
, R
5
, R
6
and X are as defined in claim
1,
act as phosphodiesterase VII inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS.
公式 I 中的 Pyrrolopyrimidine 衍生物,其中 R3、R4、R5、R6 和 X 如权利要求1所定义,作为磷酸二酯酶VII抑制剂,并可用于治疗骨质疏松症、肿瘤、消瘦症、动脉粥样硬化、类风湿性关节炎、多发性硬化症、糖尿病、炎症过程、过敏、哮喘、自身免疫性疾病、心肌疾病和艾滋病。